Business

ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) ("ReWalk" or the "Company") today announced

articleLifeward Ltd.April 3, 20194/company/rewalk-robotics-ltd/news/rewalk-robotics-announces-pricing-of-registered-direct-offering-for-dollar4250000
ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000

About this update from Lifeward Ltd.

[{"type":"text","content":"YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (\"ReWalk\" or the \"Company\") today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 816,914 ordinary shares at a purchase price of $5.2025 per ordinary share in a registered direct offering priced at-the-market.ReWalk will also issue unregistered warrants to purchase up to approximately 408,457 ordinary shares. The warrants will have a term of 5.5 years, be exercisable immediately following the issuance date and have an exercise price of $5.14 per ordinary share. The offering is expected to result in gross proceeds of approximately $4.25 million.H.C. Wainwright & Co. is acting as the exclusive placement agent in connection with this offering.The closing of the sale of the securities is expected to take place on or about April 8, 2019, subject to satisfaction of customary closing conditions.The ordinary shares described above were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-20983), which was declared effective by the United States Securities and Exchange Commission (the \"SEC\") on May 9, 2016. Such ordinary shares may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.When filed with the SEC, copies of the prospectus supplement and the accompanying prospectus relating to the registered direct offering may be obtained at the SEC's website at http://www.sec.gov. Copies of the prospectus supplement and accompanying prospectus relating to the registered direct offering may also be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by calling (646) 975-6996 or emailing [email protected] warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the \"Act\"), and, along with the ordinary shares issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements.This press release shall not constitute an offer t...

More updates from Lifeward Ltd.